Market Cap | 2.64M | P/E | - | EPS this Y | 90.40% | Ern Qtrly Grth | - |
Income | -7.1M | Forward P/E | -0.26 | EPS next Y | 59.10% | 50D Avg Chg | -23.00% |
Sales | 1.53M | PEG | -0.01 | EPS past 5Y | - | 200D Avg Chg | -60.00% |
Dividend | N/A | Price/Book | 0.54 | EPS next 5Y | 30.00% | 52W High Chg | -94.00% |
Recommedations | 2.00 | Quick Ratio | 2.88 | Shares Outstanding | 1.02M | 52W Low Chg | 1.00% |
Insider Own | 0.03% | ROA | -112.85% | Shares Float | 515.12K | Beta | 0.58 |
Inst Own | 5.19% | ROE | -238.88% | Shares Shorted/Prior | 33.55K/46.82K | Price | 0.89 |
Gross Margin | 45.06% | Profit Margin | - | Avg. Volume | 38,825 | Target Price | 35.00 |
Oper. Margin | -349.02% | Earnings Date | Nov 7 | Volume | 19,697 | Change | -2.20% |
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
HC Wainwright & Co. | Buy | May 14, 24 |
HC Wainwright & Co. | Buy | Dec 28, 23 |